INAVOLISIB
UNII L4C1UY2NYH

Substance Identification & Data

This profile provides standardized clinical and technical data for Inavolisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L4C1UY2NYH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2060571-02-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L4C1UY2NYH

CAS Registry Number

2060571-02-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INAVOLISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

L4C1UY2NYH

The specific atomic composition represented as a molecular structure string.

InChIKey

C18H19F2N5O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SGEUNORSOZVTOL-CABZTGNLSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C132166

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

124173720

Unique identification number in the NCBI database of chemical substances.

INN ID

11204

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-206

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C([C@H](C)Nc1cc2c(-c3n(CCO2)cc(n3)N4C(OC[C@H]4C(F)F)=O)cc1)(=O)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inavolisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.